Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01774344
Title Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma (RESORCE)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bayer
Indications

hepatocellular carcinoma

Therapies

Regorafenib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT


No variant requirements are available.